Skip to main content
Logo GMV

Main navigation

  • Sectors
    • Icono espacio
      Space
    • Icono Aeronáutica
      Aeronautics
    • Icono Defensa y Seguridad
      Defense and Security
    • Icono Sistemas Inteligentes de Transporte
      Intelligent Transportation Systems
    • Icono Automoción
      Automotive
    • Icono Ciberseguridad
      Cybersecurity
    • Icono Servicios públicos Digitales
      Digital Public Services
    • Icono Sanidad
      Healthcare
    • Icono Industria
      Industry
    • Icono Financiero
      Financial
    • Icono Industria
      Services
    • All Sectors

    Highlight

    Slopsquatting
    Slopsquatting: A silent threat born from the hallucinations of LLMs
  • Talent
  • About GMV
    • Get to Know the Company
    • History
    • Management Team
    • Certifications
    • Corporate Social Responsibility
  • Communication
    • News
    • Events
    • Blog
    • Magazine GMV News
    • Press Room
    • Media library
    • Latest from GMV

Secondary navigation

  • Products A-Z
  • GMV Global
    • Global (en)
    • Spain and LATAM (es - ca - en)
    • Germany (de - en)
    • Portugal (pt - en)
    • Poland (pl - en)
    • All branches and all GMV sites
  • Home
  • Communication
  • News
Back
New search
Date
  • Healthcare

Radiance, the world’s only radiosurgery planner in the Provincial Hospital of Castellón

05/02/2019
  • Print
Share
The Provincial Hospital of Castellón has taken up radiance, the world’s only radiosurgery planner

The Provincial Hospital of Castellón has chosen World Cancer Day to announce its acquisition of the cutting-edge healthcare technology  radiance™, the world’s only radiosurgery planner. This groundbreaking system allows the clinician to plan the best possible treatment for each particular cancer, calculating by means of software and algorithms the exact radiotherapy dose to be applied to each patient and the tumor bed to be treated once the tumor has been extirpated in the operating theater.

The GMV-developed planner, by determining the right radiotherapy dose beforehand, cuts down the number of post-surgery radiotherapy sessions the patient needs, with the corresponding physical and mental benefits. Optimization of the treatment also contributes towards the sustainability of the healthcare system.

As proven in clinical trials, radiance™ boosts the safety of intraoperative radiotherapy (IORT), helping the specialist to make a complete analysis of the patient and improving pre-surgery decision-making. A good example is the ELIOT y TARGIT trials that made comparisons between IORT-treated patients with small, nonmetastatic breast tumors and others not treated with this technique. In this specific case “a single dose is equivalent to 6 weeks of conventional radiotherapy” in the words of Carlos Illana, GMV’s Product Manager.

GMV has developed radiance™ in collaboration with a set of prestigious hospitals and universities like Hospital La Luz de Madrid, Hospital Doctor Negrín de Las Palmas, Hospital General Universitario Gregorio Marañón, Universidad Politécnica de Madrid and Universidad Complutense de Madrid, among others. It is still collaborating with some of these hospitals and universities and other benchmark international institutions to fine-tune the system to meet the ongoing requirements of specialists. Version 4 is now on the market.

Carlos Ferrer Albiach, Director of the Oncological Institute of the Provincial Hospital of Castellón, spoke as follows about radiance™: “Intraoperative radiotherapy is a technique for directing a single high-intensity radiation dose at the tumor bed during surgery, protecting the surrounding radiation-sensitive healthy tissue”. He goes on: “In the Provincial Hospital of Castellón radiance™ enables us to work more safely, giving us a good idea of what we will find in the operating theater in the area to be irradiated and improving our skills”, adding finally that “this type of technology is indispensable in the twenty-first century”.

Carlos Illana Alejandro, GMV’s Product Manager, stressed the fact that “this technique reduces the recurrence risk in a fair number of tumors (e.g., rectal cancer, sarcomas or breast cancer); its palliative value is also important in other types of hard-to-cure cancers like pancreatic or in relapses”. The patient benefits from “fewer hospital visits; fewer external radiotherapy sessions in certain cases like early breast cancers with favorable prognostic factors, while minimizing overspill effects on surrounding healthy tissue (chronic sequelae)”.

 

 

 

  • Print
Share

Related

Premios IA con Impacto Social
  • Healthcare
The GMV-led Tartaglia project wins the "AI with Social Impact Prize".
np_011_ia-lung-scan.jpg
  • Healthcare
Innovative artificial intelligence-based simulator for the diagnosis of interstitial lung diseases
np_011_ia-lung-scan.jpg
  • Healthcare
GMV designs a groundbreaking artificial intelligence-based simulator for diagnosing interstitial lung diseases

Contact

Contact menu

  • Contact
  • GMV around the world

Blog

  • Blog

Sectors

Sectors menu

  • Space
  • Aeronautics
  • Defense and Security
  • Intelligent Transportation Systems
  • Automotive
  • Cybersecurity
  • Digital Public Services
  • Healthcare
  • Industry
  • Financial
  • Services
  • Talent
  • About GMV
  • Shortcut to
    • Press Room
    • News
    • Events
    • Blog
    • Products A-Z
© 2025, GMV Innovating Solutions S.L.

Footer menu

  • Contact
  • Legal Notice
  • Privacy Policy
  • Cookie Policy

Footer Info

  • Commitment to the Environment
  • Financial Information